Senescent CD4+CD28null cells are increased in chronic hyperuricemia, show aberrant effector phenotypes, and are reversed after allopurinol therapy: a proof-of-concept pilot study-Reference-Cited by-同舟云学术

Senescent CD4+CD28null cells are increased in chronic hyperuricemia, show aberrant effector phenotypes, and are reversed after allopurinol therapy: a proof-of-concept pilot study

Published:2023-04-18 Issue:8 Volume:42 Page:2181-2186
ISSN:0770-3198
Container-title:Clinical Rheumatology
language:en
Short-container-title:Clin Rheumatol

Author:

Amezcua-Guerra Luis M.^ORCID,Espinosa-Bautista Fernanda,Hopf-Estandía Karen,Valdivieso-Ruiz Melisa,Coronel Dania,Robledo Sandra,Ramos-Rosillo Varna,del Rocío Martínez-Alvarado María,Patlán Mariana^ORCID,Páez Araceli^ORCID,Silveira Luis H.^ORCID,Tavera-Alonso Claudia,Massó Felipe^ORCID,Soto-Fajardo Carina^ORCID,Pineda Carlos^ORCID

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Rheumatology

Link

https://link.springer.com/content/pdf/10.1007/s10067-023-06595-8.pdf

Reference22 articles.

1. Weyand CM, Yang Z, Goronzy JJ (2014) T-cell aging in rheumatoid arthritis. Curr Opin Rheumatol 26:93–100. https://doi.org/10.1097/BOR.0000000000000011

2. Zizzo G, De Santis M, Bosello S, Tolusso B, Alivernini S, De Luca G, Gremese E, Ferraccioli G (2019) Measuring the T-cell down-regulation of TCR-zeta, ZAP-70 and CD28 in arthritis patients: an old tool for new biomarkers. Eur J Immunol 49:2195–2203. https://doi.org/10.1002/eji.201847849

3. Dumitriu IE (2015) The life (and death) of CD4+ CD28(null) T cells in inflammatory diseases. Immunology 146:185–193. https://doi.org/10.1111/imm.12506

4. Lozada-Navarro AC, Castillo-Martínez D, Moreno-Ramírez M, Acosta-Peña G, Páez A, Massó F, Márquez-Velasco R, Amezcua-Guerra LM (2018) An imbalance in the T-helper phenotypes displayed by senescent CD4+CD28null T cells is associated with erosive arthritis (rhupus syndrome) in systemic lupus erythematosus. Lupus 27:2155–2160. https://doi.org/10.1177/0961203318793715

5. Gómez-García L, Ramírez-Assad C, Vargas A, Massó F, Sánchez-Muñoz F, Márquez-Velasco R, Amezcua-Guerra LM, Bojalil R (2013) Reduced numbers of circulating CD28-negative CD4+ cells in patients with rheumatoid arthritis chronically treated with abatacept. Int J Rheum Dis 16:469–471. https://doi.org/10.1111/1756-185X.12056